Caldan Therapeutics Announces Key Appointments and a Collaboration With Sygnature Discovery
Caldan Therapeutics, a spin-out company from the Universities of Glasgow and Southern Denmark, which specialises in developing novel therapeutics targeting free fatty acid receptors for